The latest announcement is out from Aveanna Healthcare Holdings ( (AVAH) ).
Aveanna Healthcare Holdings reported robust financial growth for Q3 2024, with revenue reaching $509 million, a 6.5% increase from the previous year. The company’s strategic focus on cost reduction and partnerships led to a significant 32.2% rise in adjusted EBITDA, amounting to $47.8 million. Despite a net loss of $42.8 million, Aveanna has raised its full-year 2024 revenue guidance to $2 billion, highlighting their success in enhancing profitability and clinical outcomes.
Learn more about AVAH stock on TipRanks’ Stock Analysis page.
